Gynecologic Oncology

Follow Gynecologic Oncology
Share on
Copy link to clipboard

This new series of monthly podcasts will feature information on a wealth of emerging topics in the field of Gynecological Oncology. Each month one of our Editor's will have an in-depth conversation with the Author of a Editor's Choice article as well as the Author of the commentary/editorial that ac…

Various


    • Mar 3, 2025 LATEST EPISODE
    • monthly NEW EPISODES
    • 20m AVG DURATION
    • 99 EPISODES


    Search for episodes from Gynecologic Oncology with a specific topic:

    Latest episodes from Gynecologic Oncology

    Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study

    Play Episode Listen Later Mar 3, 2025 18:12


    Editor’s Choice: Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study Editorial: Prevention of Gestational Trophoblastic Neoplasia with Actinomycin -D at the time of evacuation: A Matter of Routine Practice or Reserve for Special Circumstances?

    Clinical trials: Panacea or pitfall

    Play Episode Listen Later Jan 27, 2025 30:47


    Editor’s Choice: Clinical trial enrollment during first course of gynecologic cancer treatment and survival Editorial: Clinical trials are not the solution to inequities in cancer care

    FOLR1 status: Landscape beyond high grade serous ovarian cancer

    Play Episode Listen Later Jan 1, 2025 20:26


    Editor’s Choice: Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma Editorial: Following the folate receptor: Expanding targeted treatment options in low grade serous ovarian carcinoma Hosted by:Warner Huh, MD, Deputy Editor of Gynecologic OncologyFeaturing: Tullia Rushton, MD Beryl L. Manning-Geist, MD

    Benefits of hormonal therapy for low grade serous ovarian cancer

    Play Episode Listen Later Jan 1, 2025 22:40


    Editor’s Choice: The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study Editorial: Hormonal maintenance therapy for advance low grade serous ovarian carcinoma appears to be of benefit – That's a relief!

    Implementation and impact of a financial navigation program in gynecologic oncology

    Play Episode Listen Later Oct 23, 2024 32:25


    Editor’s Choice: Implementation of a financial navigation program in gynecologic oncology Editorial: Financial toxicity: moving from describing the problem toward developing interventions Hosted by:Diane Yamada, MDFeaturing: Katharine M. Esselen, MDMargaret Liang, MD

    LVSI in Stage 1 Endometrial Cancer

    Play Episode Listen Later Sep 27, 2024 18:19


    Editor’s choice: The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma Editorial: Is substantial lymphovascular space invasion in FIGO stage I endometrial carcinoma ready for primetime in deciding adjuvant treatment? Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic OncologyFeaturing: Mohamed Elshaikh, MDBeriwal Sushil MD

    Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer

    Play Episode Listen Later Sep 2, 2024 31:59


    Editor’s choice: Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva Editorial: Optimizing and harmonizing lymph node dissection and radiotherapy in advanced vulvar cancer Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology Featuring: Dr Lilian T. Gien, MD, MSc, FRCSC, University of Toronto, Canada Dr Brenna Swift, MD, FRCSC, MSc, MASc, University of Toronto, Canada Dr Scott Glaser, MD, City of Hope, USA

    Shifting trends and sicker patients - the future of gynecologic cancer

    Play Episode Listen Later Jul 12, 2024 14:49


    Editor’s choice: Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists Editorial: Who you gonna call? Hosted by:David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring:M. Dwight Chen, MD, Palo Alto Foundation Medical Group/Sutter HealthConnor C. Wang, MD, Northwestern University Feinberg School of MedicineEmma Barber, MD, MS, Northwestern University Feinberg School of Medicine

    Shifting trends and sicker patients - the future of gynecologic cancer

    Play Episode Listen Later Jul 12, 2024 14:49


    Editor’s choice: Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists Editorial: Who you gonna call? Hosted by:David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring:M. Dwight Chen, MD, Palo Alto Foundation Medical Group/Sutter HealthConnor C. Wang, MD, Northwestern University Feinberg School of MedicineEmma Barber, MD, MS, Northwestern University Feinberg School of Medicine

    2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement

    Play Episode Listen Later Jul 8, 2024 37:08


    Reviews: 2023 changes to FIGO endometrial cancer staging: Counterpoint; 2023 FIGO staging system for endometrial cancer: The evolution of the revolution Editorial: 2023 FIGO staging for endometrial cancer, a look at both sides of the coin Hosted by: Sean Dowdy, MD, FACS, FACOG, Associate Editor of Gynecologic Oncology Featuring: Dr. Alexander Olawaiye, MD, University of Pittsburgh School of Medicine, USA Dr. David Gaffney, MD-PhD, University of Utah, USA Dr. Mario Leitao, Jr., MD, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, USA

    Editor's Choice: SENTIREC-endo study: Is the juice worth the squeeze?

    Play Episode Listen Later Apr 15, 2024 13:24


    Editor’s Choice Paper:Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study Editorial:Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement Hosted by:Gregg Nelson, MD, Social Media Editor of Gynecologic OncologyFeaturing:Sarah M. Bjørnholt, MD, Aarhus University Hospital, DenmarkSean Dowdy, MD, Mayo Clinic, USA

    Editor's Choice: Caring for the Caregiver

    Play Episode Listen Later Apr 4, 2024 19:40


    Editor’s Choice Paper: Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers Editorial:The importance of family-focused care in the setting of advanced gynecological cancersHosted by:Sean Dowdy, MD, Associate Editor of Gynecologic OncologyFeaturing:Rachel A. Pozzar, PhD, RN, Dana Farber Cancer Institute and Harvard Medical SchoolAllison J. Applebaum, PhD, Caregivers Clinic, Memorial Sloan Kettering Cancer Center

    December 2023 Editor's Choice: Optimization of endometrial cancer survivorship through modification of lifestyle factors

    Play Episode Listen Later Jan 29, 2024 10:18


    Editor’s Choice Paper: Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study Hosted by:Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic OncologyFeaturing:Ane Gerda Z. Eriksson, MD, Oslo University Hospital, NorwayS. J. Kitson, MD, University of Manchester, UK

    October 2023 Editor's Choice: OS updates for Imagyn50

    Play Episode Listen Later Nov 17, 2023 14:03


    Editor’s Choice Paper: Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer Hosted by:Ursula Matulonis, MD, Associate Editor of Gynecologic OncologyFeaturing:Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center

    September 2023 Editor's Choice: Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?

    Play Episode Listen Later Oct 27, 2023 16:40


    Editor’s Choice Paper: Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis? Editorial: Universal thromboprophylaxis in ovarian cancer patients before and after surgery? Hosted by:David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic OncologyFeaturing:Amanika Kumar, MD, Mayo Clinic Laura Havrilesky, MD, Duke University

    September 2023 Editor's Choice: Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?

    Play Episode Listen Later Oct 27, 2023 16:40


    Editor’s Choice Paper: Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis? Editorial: Universal thromboprophylaxis in ovarian cancer patients before and after surgery? Hosted by:David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic OncologyFeaturing:Amanika Kumar, MD, Mayo Clinic Laura Havrilesky, MD, Duke University

    August 2023 Editor's Choice: What is your center doing to improve genetic testing following abnormal MMR results in endometrial cancer?

    Play Episode Listen Later Sep 28, 2023 19:41


    Editor's Choice Papers:  Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancerEditorial: Universal testing – Should it be that hard? Probably. If you're doing it rightHosted by:Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Bhavana Pothuri, MD,NYU Perlmutter Cancer CenterLeigha Senter, MS, CGC, The Ohio State University College of Medicine

    July 2023 Editor's Choice: The evolution of patient-centered endometrial cancer detection: testing tompon-based collection for methylated DNA markers

    Play Episode Listen Later Aug 16, 2023 28:12


    Editor's Choice Papers:  Detection of endometrial cancer using tampon-based collection and methylated DNA markersEditorial: Early detection of endometrial cancerHosted by:Dineo Khabele, MD, Associate Editor of Gynecologic Oncology Featuring:Jamie N. Bakkum-Gamez, MD, Mayo ClinicJonathan C. Dudley, MD, The Johns Hopkins University School of Medicine

    July 2023 Editor's Choice: The evolution of patient-centered endometrial cancer detection: testing tompon-based collection for methylated DNA markers

    Play Episode Listen Later Aug 16, 2023 28:12


    Editor's Choice Papers:  Detection of endometrial cancer using tampon-based collection and methylated DNA markersEditorial: Early detection of endometrial cancerHosted by:Dineo Khabele, MD, Associate Editor of Gynecologic Oncology Featuring:Jamie N. Bakkum-Gamez, MD, Mayo ClinicJonathan C. Dudley, MD, The Johns Hopkins University School of Medicine

    TKI Toxicities: A Society of Gynecologic Oncology Podcast

    Play Episode Listen Later Jul 10, 2023 25:18


    TKI Toxicities: A Society of Gynecologic Oncology Podcast Moderator:Róisín O'Cearbhaill, MD, Gynecologic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York Speakers: BJ Rimel, MD, Gynecologic Oncologist, Cedars-Sinai Medical CenterErin Crane, MD, MPH, Gynecologic Oncologist, Levine Cancer InstituteVicky Makker, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Jennifer MacDonald, PharmD, Oncology Clinical Pharmacy Specialist, Medical University of South Carolina Róisín O'Cearbhaill, MD, is joined by BJ Rimel, MD, Erin Crane, MD, MPH, Vicky Makker, MD, and Jennifer McDonald, PharmD, to review the clinical management of tyrosine kinase inhibitors (TKIs) in gynecologic cancers with consideration for dose adjustments and modifications. The speakers discuss the optimal management of commonly encountered toxicities, such as hypertension and hypothyroidism, that are associated with several of the TKIs. They also highlight management strategies, patient reference materials and anticipatory prescriptions for antihypertensives, antidiarrheals, and antiemetics. The podcast includes two patient cases that delve into information about the differences in toxicities between lenvatinib and pazopanib, hypertension and which drugs to use in which order (both starting dose and dose adjustments), and medical access and lab intervals. These practical clinical pearls in managing toxicities aim to guide practitioners on how best to use these drugs to treat gynecologic cancers. This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology. Additional Resources: Tyrosine kinase inhibitor toxicities: A Society of Gynecologic Oncology review and recommendations Download audio Browse all Gynecologic Oncology audio

    TKI Toxicities: A Society of Gynecologic Oncology Podcast

    Play Episode Listen Later Jul 10, 2023 25:19


    Moderator: Róisín O'Cearbhaill, MD, Gynecologic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York Featuring: BJ Rimel, MD, Gynecologic Oncologist, Cedars-Sinai Medical Center Erin Crane, MD, MPH, Gynecologic Oncologist, Levine Cancer Institute Vicky Makker, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Jennifer MacDonald, PharmD, Oncology Clinical Pharmacy Specialist, Medical University of South Carolina

    June 2023 Editor's Choice: ERAS Society Updates: What Every Gyn Oncologist Should Know

    Play Episode Listen Later Jul 3, 2023 27:27


    Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology Featuring: Gregg Nelson, MD, University of Calgary Sean Dowdy, MD, Mayo Clinic College of Medicine Olle Ljungqvist, MD, Örebro University Hospital Editor's Choice Papers: Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update

    June 2023 Editor's Choice: ERAS Society Updates: What Every Gyn Oncologist Should Know

    Play Episode Listen Later Jul 1, 2023 27:27


    Editor's Choice Papers:  Enhanced recovery after surgery (ERAS reg) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update Editorial:  Gynecologic oncology surgery – Ready for the next step in ERASHosted by:Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology Featuring: Gregg Nelson, MD, University of CalgarySean Dowdy, MD, Mayo Clinic College of MedicineOlle Ljungqvist, MD, Orebro University Hospital

    May 2023 Editor's Choice: Prioritizing and achieving diversity in clinical trial enrollment

    Play Episode Listen Later Jun 21, 2023 39:45


    Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Ann Oluloro, MD, MPH, University of Washington Eloise Chapman-Davis, MD, Weill Cornell Medicine Editor's Choice Papers: What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black women

    April 2023 Editor's Choice: The times they are a changin' – the future of the specialty

    Play Episode Listen Later May 15, 2023 20:24


    Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Stephanie V. Blank, MD, Icahn School of Medicine at Mount Sinai Warner K. Huh, MD, FACOG, FACS, University of Alabama Birmingham Editor's Choice Papers: Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report

    April 2023 Editor's Choice: The times they are a changin' – the future of the specialty

    Play Episode Listen Later May 12, 2023 20:24


    Editor's Choice Papers:  Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report Editorial:  “The times they are a-changin'” – And how are we managing?Hosted by:David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Stephanie V. Blank,MD, Icahn School of Medicine at Mount SinaiWarner K. Huh, MD, FACOG, FACS, University of Alabama Birmingham        

    March 2023 Editor's Choice: Intrathoracic Surgery and Ovarian Cancer Cytoreduction: Why the Chest Matters

    Play Episode Listen Later Apr 11, 2023 26:18


    Editor's Choice Papers:  Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study Editorial: Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: The evolution of a “pelvic” surgeon Hosted by:Warner K. Huh, MD, FACOG, FACS, Deputy Editor of  Gynecologic Oncology Featuring: Ryan M. Kahn MD,FACOG, Memorial Sloan Kettering Cancer Center Dennis Chi, MD, Memorial Sloan Kettering Cancer CenterProf Christina Fotopoulou, Imperial College London, UK    

    March 2023 Editor's Choice: Intrathoracic Surgery and Ovarian Cancer Cytoreduction: Why the Chest Matters

    Play Episode Listen Later Apr 10, 2023 26:18


    Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Ryan M. Kahn MD, FACOG, Memorial Sloan Kettering Cancer Center Dennis Chi, MD, Memorial Sloan Kettering Cancer Center Prof Christina Fotopoulou, Imperial College London, UK Editor's Choice Papers: Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

    February 2023 Editor's Choice: A Geo-Analyzer Tool that assessed insured patients in your metropolitan area with recurrent and metastatic cervix cancer

    Play Episode Listen Later Mar 14, 2023 27:23


    Hosted by: Wendy R. Brewster, MD, PhD, Deputy Editor of Gynecologic Oncology Featuring: Turgay Ayer, Georgia Institute of Technology Tara Castellano, MD, Louisiana State University HSC Isabel C. Scarinci, PhD, MPH, University of Alabama at Birmingham Editor's Choice Papers: Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer Editorial: Targeting our efforts: the contribution of an open-access tool to assess geographic distribution of recurrent and metastatic cervical cancer

    January 2023 Editor's Choice: Sentinel lymph node mapping in endometrial complex atypical hyperplasia: good idea or have we gone too far?

    Play Episode Listen Later Feb 22, 2023 25:51


    Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Jennifer Mueller MD, Memorial Sloan Kettering Cancer Center Emad Matanes MD, Rambam Medical Center Emma Rossi MD, Duke University Medical Center Editor's Choice Papers: Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia? Editorial: Routine SLN biopsy for endometrial intraepithelial neoplasia: A pragmatic approach or over-treatment?

    Molecular Testing for Endometrial Cancer: A Society of Gynecologic Oncology Podcast

    Play Episode Listen Later Feb 7, 2023 17:46


    Moderator: Kari Hacker, MD, PhD, Gynecologic Oncologist, New York University Langone Health Speakers: Christine Walsh, MD, MS, Gynecologic Oncologist, University of Colorado Carolyn McCourt, MD, Gynecologic Oncologist, Washington University School of Medicine Kari Hacker, MD, PhD, is joined by Christine Walsh, MD, MS, and Carolyn McCourt, MD, to review basic molecular classification as well as more complex biomarkers in endometrial cancer. They discuss how testing can be utilized to inform patient prognosis and to guide second line systemic treatment decisions. They also highlight several ongoing trials investigating treatment strategies based on molecular features, the results of which will help clinicians make better therapeutic decisions, resulting in better outcomes for patients with endometrial cancer. This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology. Additional Resources: Molecular testing for endometrial cancer: An SGO clinical practice statement

    January 2023 Editor's Choice: Sentinel lymph node mapping in endometrial complex atypical hyperplasia: good idea or have we gone too far?

    Play Episode Listen Later Jan 5, 2023


    Editor's Choice Papers:  Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia? Editorial: Routine SLN biopsy for endometrial intraepithelial neoplasia: A pragmatic approach or over-treatment? Hosted by:Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Jennifer Mueller MD, Memorial Sloan Kettering Cancer CenterEmad Matanes MD, Rambam Medical CenterEmma Rossi MD, Duke University Medical Center    

    Burnout and gynecologic oncology - does the problem still exist?

    Play Episode Listen Later Jan 5, 2023


    Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring:Brittany A. Davidson, MD, Duke UniversityDavid M. Kushner, MD, UW School of Medicine and Public Health Article: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology

    Burnout and gynecologic oncology — does the problem still exist?

    Play Episode Listen Later Dec 23, 2022 23:17


    Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Brittany A. Davidson, MD, Duke University, David M. Kushner, MD, UW School of Medicine and Public Health Article: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology

    December 2022 Editor's Choice: Exceptional PARP inhibitor responders: the good and the bad

    Play Episode Listen Later Dec 22, 2022 22:51


    Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology and Author of the editorial Featuring: David O'Malley, MD, The Ohio State University Editor's Choice Paper: Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma Editorial: The rapid evolution of PARP inhibitor therapy for advanced ovarian cancer: Lessons being learned and new questions emerging from phase 3 trial long-term outcome data

    November 2022 Editor's Choice: Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?

    Play Episode Listen Later Dec 13, 2022 22:23


    Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology Featuring: David M. Gershenson, MD, The University of Texas MD Anderson Cancer Center Charlie Gourley, MD, Nicola Murray Centre for Ovarian Cancer Research Editor's Choice Paper: Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival Editorial: Low grade serous ovarian cancer: Unpicking drivers of outcome

    November 2022 Editor's Choice: Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?

    Play Episode Listen Later Nov 3, 2022


    Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic OncologyFeaturing:David M. Gershenson, MD, The University of Texas MD Anderson Cancer CenterCharlie Gourley, MD, Nicola Murray Centre for Ovarian Cancer ResearchEditor's Choice Paper: Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival Editorial: Low grade serous ovarian cancer: Unpicking drivers of outcome

    October 2022 Editor's Choice: How do you manage the contralateral groin in early stage vulvar cancer with a unilateral positive sentinel lymph node?

    Play Episode Listen Later Oct 25, 2022 22:24


    Hosted by: S. Diane Yamada, MD, Deputy Editor of Gynecologic Oncology Featuring: Maaike Oonk, MD, University Medical Center Groningen, University of Groningen, The Netherlands Akila Viswanathan, MD, MPH, Johns Hopkins Medicine Editor's Choice Paper: Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe Editorial:When is it safe to omit contralateral groin management in unilateral sentinel node-positive early stage vulvar cancer?

    September 2022 Editor's Choice: Frailty assessment in gynecologic oncology - have you incorporated this into your practice?

    Play Episode Listen Later Sep 28, 2022 16:57


    Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Mariam M. AlHilli, MD Gynecologic Oncologist, Cleveland Clinic, Cleveland Ohio Amanika Kumar, MD, Mayo Clinic Division of Gynecologic Surgery, Rochester, Minnesota Editor's Choice Paper: Preoperative assessment using the five-factor modified frailty index: A call for standardized preoperative assessment and prehabilitation services in gynecologic oncology Editorial: Answering the call: Are we ready for action on frailty in gynecologic oncology?

    August 2022 Editor's Choice: Financial toxicity – the other side effect of cancer care

    Play Episode Listen Later Sep 9, 2022 14:40


    Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Joshua G. Cohen, MD, Gynecologic Oncologist, City of Hope Orange County Fumiko Chino, MD, Affordability Working Group, Radiation Oncologist, Memorial Sloan Kettering Cancer Center Editor's Choice Paper: Insurance-based disparities and risk of financial toxicity among patients undergoing gynecologic cancer operations Editorial: Financial toxicity of surgical treatment for gynecological cancer: A growing malignancy

    July 2022 Editor's Choice: Complications after cytoreductive surgery and its impact on survival: where do we go from here?

    Play Episode Listen Later Aug 5, 2022 18:13


    Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Pr Alejandra Martinez, Institut Universitaire du Cancer de Toulouse Oncopole Jill Tseng, MD, UC Irvine Health Editor's Choice Paper: The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer Editorial: Complications associated with cytoreductive surgery for advanced ovarian cancer: Surgical timing and surmounting obstacles

    July 2022 Editor's Choice: Complications after cytoreductive surgery and its impact on survival: where do we go from here?

    Play Episode Listen Later Aug 5, 2022 18:13


    Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Pr Alejandra Martinez, Institut Universitaire du Cancer de Toulouse Oncopole Jill Tseng, MD, UC Irvine Health Editor's Choice Paper: The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer Editorial: Complications associated with cytoreductive surgery for advanced ovarian cancer: Surgical timing and surmounting obstacles

    June 2022 Editor's Choice: Long-term cardiovascular complications among gynecologic cancer survivors

    Play Episode Listen Later Jul 15, 2022 16:02


    Hosted by: Jose Alejandro Rauh-Hain, MD, MPH, Associate Editor of Gynecologic Oncology Featuring: Steven S. Coughlin, MD, Augusta University Daniel Addison, MD, The Ohio State University Wexner Medical Center Editor's Choice Paper: Cardiovascular conditions and obesity among gynecologic cancer survivors: Results from the 2020 behavioral risk factor surveillance system survey Editorial: The intersection of gynecologic cancer, obesity, and cardiovascular disease

    Immunotherapy Toxicities: A Society of Gynecologic Oncology Podcast

    Play Episode Listen Later Jul 15, 2022 14:03


    Moderator: Leslie Clark, MD, Gynecologic Oncologist, University of North Carolina in Chapel Hill Speakers: Róisín O'Cearbhaill, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Ramez Eskander, MD, Gynecologic Oncologist, University of California San Diego Additional Resources: Immunotherapy toxicities: An SGO clinical practice statement

    May 2022 Editor's Choice: The ProMisE of molecular classification to standardize care in endometrial cancer

    Play Episode Listen Later Jun 9, 2022 17:59


    Hosted by: S. Diane Yamada, MD, Deputy Editor of Gynecologic Oncology Featuring: Jessica N. McAlpine, MD, University of British Columbia G. Larry Maxwell, MD, FACOG, COL(ret) USA, Inova Health System Editor's Choice Paper: Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification Editorial: The ProMisE of uniform care for endometrial cancer patients

    April 2022 Editor's Choice: Reducing non-surgical readmissions in gynecologic oncology

    Play Episode Listen Later May 12, 2022 17:59


    Hosted by: John Farley, MD, Associate Editor of Gynecologic Oncology Featuring: Catherine H. Watson, MD, Vanderbilt University Medical Center Larissa Alejandra Meyer, MD MPH, The University of Texas MD Anderson Cancer Center Editor's Choice Paper: Reducing non-surgical readmissions on a gynecologic oncology service Editorial: Our dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator

    March 2022 Editor's Choice: HRD: Improving QOL for patients with cervical cancer: SLN biopsy

    Play Episode Listen Later Apr 25, 2022 18:23


    Hosted by: Sean C. Dowdy, MD, Associate Editor of Gynecologic Oncology Featuring: Sara Elisabeth Sponholtz, MD, PhD, University of Southern Denmark Mario M. Leitao, Jr., MD, Memorial Sloan-Kettering Cancer Center Editor's Choice Paper: SENTIREC - The sentinel node mapping in women with cervical cancer study - Patient-reported early lymphedema and its impact on quality of life Editorial: The end of routine lymphadenectomy for the treatment of cervical cancer is rapidly approaching

    April 2022 Editor's Choice: Reducing non-surgical readmissions in gynecologic oncology

    Play Episode Listen Later Apr 7, 2022


    Hosted by: John Farley, MD, Associate Editor of Gynecologic Oncology Featuring: Catherine H. Watson, MD, Vanderbilt University Medical Center Larissa Alejandra Meyer, MD MPH, The University of Texas MD Anderson Cancer Center Editor's Choice Paper: Reducing non-surgical readmissions on a gynecologic oncology service Editorial: Our dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator

    February 2022 Editor's Choice: HRD: What does it really mean and are we looking at this the right way?

    Play Episode Listen Later Mar 3, 2022 17:59


    Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Elizabeth Swisher, MD, UW Medicine Jonathan A Ledermann MD FRCP FMedSci Professor of Medical Oncology, UCL Cancer Institute Editor's Choice Paper: Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study Editorial: Testing for homologous recombination deficiency – does it provide new insights for the use of veliparib?

    January 2022 Editor's Choice: Optimizing Rural Ovarian Cancer Care

    Play Episode Listen Later Feb 11, 2022 14:18


    Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Kristin Weeks, MD/PhD candidate, University of Iowa David Shalowitz, MD, MSHP, Wake Forest School of Medicine Center Editor's Choice Paper: Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients Editorial: Defining the essential role of the gynecologic oncologist in rural ovarian cancer care delivery

    February 2022 Editor's Choice: HRD: What does it really mean and are we looking at this the right way?

    Play Episode Listen Later Feb 3, 2022


    Hosted by:  Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Elizabeth Swisher, MD, UW Medicine Jonathan A Ledermann, MD FRCP FMedSci Professor of Medical Oncology, UCL Cancer Institute Editor's Choice Paper: Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study Editorial: Testing for homologous recombination deficiency – does it provide new insights for the use of veliparib?

    Claim Gynecologic Oncology

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel